Health‐related quality of life · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hepatitis B‐related mortality · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hepatitis B‐related morbidity · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐serious adverse events Maximum · chronic hepatitis B
It is very uncertain whether radix Sophorae flavescentis changes proportion of participants with ≥ 1 adverse events considered 'not… compared with other drugs or herbs (very low certainty).
1 finding from 1 review
Exploratory outcome: Proportion of participants with detectable HBV‐DNA (at maximum · chronic hepatitis B
It is very uncertain whether radix Sophorae flavescentis changes exploratory outcome: Proportion of participants with detectable… compared with other drugs or herbs (very low certainty).
1 finding from 1 review
Exploratory outcome: Proportion of participants with detectable HBeAg (at maximum · chronic hepatitis B
It is very uncertain whether radix Sophorae flavescentis changes exploratory outcome: Proportion of participants with detectable… compared with other drugs or herbs (very low certainty).
1 finding from 1 review
All‐cause mortality · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
Proportion of participants with 1 or more serious adverse events · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
Health‐related quality of life · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
Hepatitis B‐related mortality · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
Hepatitis B‐related morbidity · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
Non‐serious adverse events Maximum · chronic hepatitis B
It is very uncertain whether acupuncture changes proportion of participants with 1 or more adverse events considered… compared with no intervention (very low certainty).
1 finding from 1 review
Exploratory outcome: Proportion of participants with detectable HBV‐DNA (at maximum · chronic hepatitis B
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Interventions · people with cirrhosis and spontaneous bacterial peritonitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Liver transplantation · people with cirrhosis and spontaneous bacterial peritonitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Ciprofloxacin (2 RCT; 275 participants) · people with cirrhosis and spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes ciprofloxacin (2 RCT; 275 participants) (very low certainty).
1 finding from 1 review
HR 0.93 [0.69, 1.25]
Studies not reported
Very low
Intervention not reported
Cefotaxime (1 RCT; 37 participants) · people with cirrhosis and spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes cefotaxime (1 RCT; 37 participants) (very low certainty).
1 finding from 1 review
HR 0.56 [0.11, 2.28]
Studies not reported
Very low
Intervention not reported
Ciprofloxacin (1 RCT; 35 participants) · people with cirrhosis and spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes ciprofloxacin (1 RCT; 35 participants) (very low certainty).
1 finding from 1 review
HR 0.65 [0.12, 2.72]
Studies not reported
Very low
Intervention not reported
Ceftazidime (No direct RCT) · people with cirrhosis and spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes ceftazidime (No direct RCT) (very low certainty).
1 finding from 1 review
HR 1.15 [0.17, 6.37]
Studies not reported
Very low
Intervention not reported
Amikacin (No direct RCT) · people with cirrhosis and spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes amikacin (No direct RCT) (very low certainty).
1 finding from 1 review
HR 0.76 [0.09, 5.9]
Studies not reported
Very low